BIOA_B fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
BioArctic AB engages in the research and development of modifying treatments and diagnostics for neurodegenerative diseases. Its research areas are Alzheimer’s disease and Parkinson’s disease where there are large unmet medical needs. The company was founded by Lars Gunnar Lannfelt and Pär Lars Gellerfors in 2003 and is headquartered in Stockholm, Sweden.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
BIOA_B has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company